• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国在 COVID-19 大流行的头 2 年超额死亡人数的演变。

The Evolution of Excess Deaths in the United States During the First 2 Years of the COVID-19 Pandemic.

出版信息

Am J Epidemiol. 2023 Nov 10;192(12):1949-1959. doi: 10.1093/aje/kwad127.

DOI:10.1093/aje/kwad127
PMID:37222463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10988222/
Abstract

Understanding consequences of the COVID-19 pandemic requires information on the excess mortality resulting from it. Multiple studies have examined excess deaths during the pandemic's initial stages, but how these have changed over time is unclear. National- and state-level death counts and population data from 2009 to 2022 were used in this analysis to evaluate excess fatalities from March 2020 to February 2021 and March 2021 to February 2022, with deaths from earlier years used to project baseline counts. The outcomes were total, group-specific, cause-specific, and age-by-cause excess fatalities, and numbers and percentages directly involving COVID-19. Excess deaths declined from 655,735 (95% confidence interval: 619,028, 691,980) during the first pandemic year to 586,505 (95% confidence interval: 532,823, 639,205) in the second. The reductions were particularly large for Hispanics, Blacks, Asians, seniors, and residents of states with high vaccination rates. Excess deaths increased from the first to second year for persons younger than 65 years and in low-vaccination states. Excess mortality from some diseases declined, but those from alcohol, drug, vehicle, and homicide causes likely increased between the first and second pandemic year, especially for prime-age and younger individuals. The share of excess fatalities involving COVID-19 decreased modestly over time, with little change in its role as an underlying versus contributing cause of death.

摘要

了解 COVID-19 大流行的后果需要了解其导致的超额死亡人数。多项研究已经检查了大流行初期的超额死亡人数,但这些数字随时间的变化情况尚不清楚。本分析使用了 2009 年至 2022 年的国家和州级死亡人数和人口数据,以评估 2020 年 3 月至 2021 年 2 月和 2021 年 3 月至 2022 年 2 月的超额死亡人数,使用前几年的死亡人数来预测基线人数。结果包括总超额死亡人数、特定群体的超额死亡人数、特定原因的超额死亡人数以及按年龄和原因的超额死亡人数,以及直接涉及 COVID-19 的死亡人数和百分比。与第一年相比,第二年的超额死亡人数从 655735 人(95%置信区间:619028 人,691980 人)下降到 586505 人(95%置信区间:532823 人,639205 人)。降幅在西班牙裔、非裔、亚裔、老年人以及疫苗接种率高的州的居民中尤其明显。与第一年相比,65 岁以下人群和疫苗接种率低的州的超额死亡人数在第二年有所增加。一些疾病的超额死亡率有所下降,但酒精、药物、车辆和凶杀等原因的超额死亡率在第一年和第二年之间可能有所增加,尤其是在主要年龄组和更年轻的人群中。涉及 COVID-19 的超额死亡人数占比随时间略有下降,但其作为根本或促成死亡原因的作用变化不大。

相似文献

1
The Evolution of Excess Deaths in the United States During the First 2 Years of the COVID-19 Pandemic.美国在 COVID-19 大流行的头 2 年超额死亡人数的演变。
Am J Epidemiol. 2023 Nov 10;192(12):1949-1959. doi: 10.1093/aje/kwad127.
2
Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths.美国县的超额自然原因死亡率及其与报告的 COVID-19 死亡的关联。
Proc Natl Acad Sci U S A. 2024 Feb 6;121(6):e2313661121. doi: 10.1073/pnas.2313661121. Epub 2024 Feb 1.
3
Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US.美国 COVID-19 大流行期间,阿尔茨海默病和相关痴呆症作为根本或促成原因导致的超额死亡率。
JAMA Neurol. 2023 Sep 1;80(9):919-928. doi: 10.1001/jamaneurol.2023.2226.
4
Monthly excess mortality across counties in the United States during the COVID-19 pandemic, March 2020 to February 2022.美国 COVID-19 大流行期间各州县 2020 年 3 月至 2022 年 2 月的月度超额死亡率。
Sci Adv. 2023 Jun 23;9(25):eadf9742. doi: 10.1126/sciadv.adf9742.
5
Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations.美国 COVID-19 大流行期间不明原因死亡率:死亡证明数据的回顾性分析和对超额死亡计算的批判性评估。
BMJ Open. 2021 Nov 16;11(11):e050361. doi: 10.1136/bmjopen-2021-050361.
6
Excess deaths by sex and Age Group in the first two years of the COVID-19 pandemic in the United States.美国 COVID-19 大流行头两年按性别和年龄组划分的超额死亡人数。
Health Care Manag Sci. 2022 Sep;25(3):515-520. doi: 10.1007/s10729-022-09606-3. Epub 2022 Aug 23.
7
Excess deaths in the United States during the first year of COVID-19.美国在 COVID-19 大流行的第一年的超额死亡人数。
Prev Med. 2022 Sep;162:107174. doi: 10.1016/j.ypmed.2022.107174. Epub 2022 Jul 22.
8
Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022.2020 年 3 月 1 日至 2022 年 1 月 1 日期间美国 COVID-19 大流行的直接和间接死亡影响。
Elife. 2023 Feb 22;12:e77562. doi: 10.7554/eLife.77562.
9
Impact of Population Growth and Aging on Estimates of Excess U.S. Deaths During the COVID-19 Pandemic, March to August 2020.人口增长和老龄化对 2020 年 3 月至 8 月美国 COVID-19 大流行超额死亡估计数的影响。
Ann Intern Med. 2021 Apr;174(4):437-443. doi: 10.7326/M20-7385. Epub 2020 Dec 15.
10
Temporal variation of excess deaths from diabetes during the COVID-19 pandemic in the United States.美国 COVID-19 大流行期间糖尿病超额死亡的时间变化。
J Infect Public Health. 2023 Apr;16(4):483-489. doi: 10.1016/j.jiph.2023.01.018. Epub 2023 Jan 25.

引用本文的文献

1
Sustained excess all-cause mortality post COVID-19 in 21 countries: an ecological investigation.21个国家新冠疫情后全因死亡率持续过高:一项生态学调查
Int J Epidemiol. 2025 Apr 12;54(3). doi: 10.1093/ije/dyaf075.
2
Contribution of deaths of despair to the Hispanic mortality advantage in the USA by person, place and time: an ecological analysis of vital registration data.绝望导致的死亡对美国西班牙裔人口死亡率优势的个人、地区和时间贡献:生命登记数据的生态分析
BMJ Public Health. 2024 Aug 30;2(2):e001191. doi: 10.1136/bmjph-2024-001191. eCollection 2024 Dec.
3
Health Care Personnel Attitudes Toward Pediatric COVID-19 Vaccines.医护人员对儿童新冠疫苗的态度。
PRiMER. 2024 Oct 4;8:53. doi: 10.22454/PRiMER.2024.405060. eCollection 2024.
4
Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020-2022: a study using nationwide population data.2020-2022 年 COVID-19 大流行期间丹麦、芬兰、挪威和瑞典的特定原因超额死亡率:一项使用全国人口数据的研究。
Eur J Epidemiol. 2024 Sep;39(9):1037-1050. doi: 10.1007/s10654-024-01154-0. Epub 2024 Sep 16.
5
US State Restrictions and Excess COVID-19 Pandemic Deaths.美国各州的限制措施与新冠肺炎疫情超额死亡人数
JAMA Health Forum. 2024 Jul 5;5(7):e242006. doi: 10.1001/jamahealthforum.2024.2006.

本文引用的文献

1
The Young were not Spared: What Death Certificates Reveal about Non-Covid Excess Deaths.《年轻人未能幸免:死亡证明揭示的非新冠超额死亡情况》。
Inquiry. 2022 Jan-Dec;59:469580221139016. doi: 10.1177/00469580221139016.
2
Life expectancy loss among Native Americans during the COVID-19 pandemic.新冠疫情期间美国原住民的预期寿命损失
Demogr Res. 2022 Jul-Dec;47:233-246. doi: 10.4054/demres.2022.47.9. Epub 2022 Jul 27.
3
Vaccination rates and COVID outcomes across U.S. states.美国各州的疫苗接种率和 COVID 结果。
Econ Hum Biol. 2022 Dec;47:101201. doi: 10.1016/j.ehb.2022.101201. Epub 2022 Nov 21.
4
Pandemic And Recession Effects On Mortality In The US During The First Year Of COVID-19.新冠疫情大流行和经济衰退对美国 COVID-19 疫情第一年死亡率的影响。
Health Aff (Millwood). 2022 Nov;41(11):1550-1558. doi: 10.1377/hlthaff.2022.00364.
5
Excess deaths in the United States during the first year of COVID-19.美国在 COVID-19 大流行的第一年的超额死亡人数。
Prev Med. 2022 Sep;162:107174. doi: 10.1016/j.ypmed.2022.107174. Epub 2022 Jul 22.
6
Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic.新冠大流行第一年美国成年人中具有临床意义的焦虑和抑郁的估计患病率及相关因素。
JAMA Netw Open. 2022 Jun 1;5(6):e2217223. doi: 10.1001/jamanetworkopen.2022.17223.
7
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.在 COVID-19 大流行期间,丁丙诺啡和纳曲酮控释制剂的种族和民族差异。
JAMA Netw Open. 2022 Jun 1;5(6):e2214765. doi: 10.1001/jamanetworkopen.2022.14765.
8
Changes in Life Expectancy Between 2019 and 2020 in the US and 21 Peer Countries.2019年至2020年美国及21个同类国家的预期寿命变化。
JAMA Netw Open. 2022 Apr 1;5(4):e227067. doi: 10.1001/jamanetworkopen.2022.7067.
9
The US Midlife Mortality Crisis Continues: Excess Cause-Specific Mortality During 2020.美国中年死亡率危机持续:2020 年特定原因超额死亡率。
Am J Epidemiol. 2022 Sep 28;191(10):1677-1686. doi: 10.1093/aje/kwac055.
10
Risks and burdens of incident diabetes in long COVID: a cohort study.长期新冠患者新发糖尿病的风险与负担:一项队列研究。
Lancet Diabetes Endocrinol. 2022 May;10(5):311-321. doi: 10.1016/S2213-8587(22)00044-4. Epub 2022 Mar 21.